Institutional demand for $HYPE is accelerating faster than you think. Sonnet BioTherapeutics is merging with Rorschach to form Hyperliquid Strategies Inc ($HSI), a public crypto treasury company on Nasdaq. More details: 🔹 Holding 12.6 million $HYPE (1.26% of total supply) worth $583 million. 🔹 $305 million cash ready to buy more $HYPE 🔹 US investors unable to buy $HYPE can now gain exposure via HSI 🔹 Rebranding to a new ticker and symbol on Nasdaq (HSI) 🔹 Investor backing by Paradigm, Galaxy, Pantera, D1, Republic, 683 Capital I said I expected more TradFi players to follow and that's exactly what's happening, and there will now be two tickers on Nasdaq tied directly to $HYPE. Nearly a whole yard... fully grasp that. This is the MSTR of $HYPE.
Alan
Alan1.7.2025
I missed this the other day. Eyenovia, a Nasdaq-listed eye tech company, bought 1.3M+ $HYPE tokens at an average price of $34.83/token. Here’s what’s wild: • First public U.S. company to build a crypto treasury with $HYPE • First public company to run a Hyperliquid validator • Rebranding to Hyperion DeFi ($HYPD) Instead of stacking $BTC like other companies, they went fully onchain and made a massive bet on $HYPE. This just shows how big $HYPE is becoming, and I expect more TradFi players to eventually follow when they discover productive crypto assets. Funny enough, their stock is actually up 130% since they first announced their $HYPE buys 😂
11,73K